Sexual and genderminorities (SGMs) have been documented in every region of the world. In spite of reported
abuse, discrimination and stigma, little is known about their mental health (MH). Even less is known about the
development of appropriate MH treatment interventions. Evidence-based treatments (EBTs) addressing poor
MH are being implemented in low- and middle-income countries (LMICs) using appropriate, affordable and
sustainable delivery modalities (e.g. lay providers, mHealth). These advances create opportunities to provide
MH care to SGMs not previously possible. To develop and implement EBTs, longitudinal research is necessary
to inform us of the unique MH needs, determinants and treatment preferences of this understudied population.
Pilot data for this study suggest that: SGMs can be identified and recruited in LMICs across SGM groups;
prevalence of depression, anxiety, suicidal ideation, and posttraumatic stress disorder among SGMs is
extremely high; and there are variations in MH symptomatology and determinants by SGM group and country.
There is an urgent need for longitudinal cohort studies that include SGMs from heterogeneous LMICs to
understand the influence of culture and context on MH needs, predictors and EBT preferences, and to develop
locally sustainable EBTs and methods for generalizability. Inclusion of methods (i.e. Discrete Choice
Experiments) that identify optimal EBT approaches specific to SGM groups, culture and context will accelerate
the translation of observational research to EBT implementation and provide a model that can be used to
identify appropriate EBTs for SGMs in other diverse contexts and low resource settings. The SGM Mental
Health in LMICs (SMILE) study represents paradigm-shifting research by defining SGMs based on gender
identity and attraction -inherent biological characteristics- rather than sexual behavior. SMILE study aims are:
Aim 1: Estimate prevalence of anxiety, depression, PTSD, suicidal ideation and substance abuse
symptomatology among 7 SGM groups in 3 culturally diverse LMICs (Brazil, Kenya, Vietnam)
Aim 2: Identify cultural, contextual, interpersonal and individual determinants of MH over time, by and
across SGM group and country.
Aim 3: Determine SGMs’ MH intervention preferences through Discrete Choice Experiments (DCEs).
To accomplish these aims we will use a two-pronged recruitment strategy that includes respondent-driven
sampling and a mass media campaign to develop a cohort of 10,500 SGM (500 participants from 7 SGM
groups in 3 countries). Study participants will complete online surveys at baseline, 12- and 24-months to
assess MH symptomology, determinants, and treatment preferences. DCEs will be developed and included in
the 24-month survey to elicit preferences for EBTs that are SGM group, culture and context specific.
SMILE addresses all three NIMH priorities identified in the Notice of Special Interest in Research on Health
of SGM Populations (NOT-MD-19-001) and priorities of two other NIH Program Announcements.
Public Health Relevance Statement
Project Narrative – Sexual and Gender Minority (SGM) Mental Health In Low and Middle
Income Countries (SMILE)
SMILE will characterize the mental health symptomatology and needs of seven different SGM
groups in three culturally and contextually distinct LMICs. Respondent Driven Sampling (RDS)
as well as mass media recruitment will be used to enroll a longitudinal cohort; the cultural,
contextual, interpersonal, and individual determinants of mental health outcomes over 24
months will be identified. Discrete Choice Experiments (DCEs) will be used to elicit SGM
preferences for different characteristics of evidence-based mental health treatments (EBTs) that
can be feasibly provided and sustained for this very vulnerable population.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Abuse ReportingAccelerationAddressAlcohol dependenceAnxietyAttentionBiologic CharacteristicBrazilCaringCharacteristicsCohort StudiesCountryCross-Sectional StudiesDataDevelopmentDiscriminationDrug AddictionEnrollmentEvidence based treatmentExclusionFamilyFeeling suicidalGenderGender IdentityGoalsGovernmentGrief reactionHIVHIV/STDHealthcare SystemsHeterosexualsIncomeIndividualInterventionKenyaLearningLongitudinal cohortLongitudinal cohort studyMass MediaMedia CampaignMental DepressionMental HealthMental Health ServicesMental disordersMethodsMinority Health ResearchModalityModelingMorbidity - disease rateNIH Program AnnouncementsNational Institute of Mental HealthObservational StudyOnline SystemsOutcomeParticipantPersonsPolicePoliciesPoliticsPopulationPost-Traumatic Stress DisordersPrevalenceProviderPublic PolicyReligionResearchResource-limited settingResourcesRespondentRisk FactorsRuralSTI preventionSamplingSex BehaviorSexual and GenderMinoritiesSocial NetworkSpeedSubstance abuse problemSupport SystemSurveysSystemTimeTranslationsUnited States National Institutes of HealthVariantVietnamVulnerable PopulationsWomanalcohol and other drugcohortcombat veteranevidence baseexperimental studyfamily supportgender minority groupgender nonconforminginterestlongitudinal analysislow and middle-income countriesmHealthmenmen who have sex with menpreferenceprogramsprotective factorsrecruitrisk predictionscale upsexual minority groupsexual minority healthsocial stigmastressorsymptomatologytransgender mentransgender women
No Sub Projects information available for 5R01MH119101-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01MH119101-04
Patents
No Patents information available for 5R01MH119101-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01MH119101-04
Clinical Studies
No Clinical Studies information available for 5R01MH119101-04
News and More
Related News Releases
No news release information available for 5R01MH119101-04
History
No Historical information available for 5R01MH119101-04
Similar Projects
No Similar Projects information available for 5R01MH119101-04